Home » HUMAN GENOME SCIENCES REPORTS FINANCIAL RESULTS FOR FULL YEAR AND FOURTH QUARTER 2005
HUMAN GENOME SCIENCES REPORTS FINANCIAL RESULTS FOR FULL YEAR AND FOURTH QUARTER 2005
Human Genome Sciences, Inc. financial results for the quarter and full-year
periods ended December 31, 2005, and reiterated guidance for financial results
anticipated for 2006. The Company's net loss for 2005, in accordance with Generally
Accepted Accounting Principles (GAAP), was $239.4 million, or $1.83 per share.
This compares to the net loss for 2004 of $242.9 million, or $1.87 per share.
Yahoo
News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May